Hospital Universitario Infanta Leonor-INTERNAL MED
Madrid 28031
2 studies enrolling now · 4 studies all time
What they study most
Alopecia, Areata Alopecia, COVID-19, Chronic Lymphocytic Leukemia, Hair Diseases, Hypotrichosis, Leukemia, B-cell, Leukemia, Lymphocytic, Pathological Conditions, Anatomical, Skin Diseases, Small Lymphocytic Lymphoma
Studies at this site
- A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) — Recruiting now
- A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata — Recruiting now
- Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) — Running, not enrolling
- A Study of Baricitinib (LY3009104) in Participants With COVID-19 — Completed